NBIX Award Disclosure
Abernethy Matt · SEC Form 4 · Filed Sep 15, 2026
Award
Calculated transaction value
$0
Abernethy Matt Chief Financial Officer
NBIX
Transaction date
Sep 11, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed 4 days later
NBIX daily price context
Close on/before transaction
$156.22
Sep 11, 2026
Close before public filing
$157.22
Sep 14, 2026
Return since public filing
-3.91%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,020 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001724097-26-000010
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$786.48K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Sale | Sep 14, 2026 | $363.28K |
| Neurocrine Biosciences Inc NBIX Current | Award | Sep 11, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Disposition | Sep 11, 2026 | $423.2K |